Dr. Falk Pharma Gmbh v. Generico, LLC

Procedural entryThis page is a short order in Dr. Falk Pharma Gmbh v. Generico, LLC. Read the opinion of the Court — 916 F.3d 975
Court of Appeals for the Federal Circuit·Decided July 11, 2019·No. 17-2312·Unpublished

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

July 11, 2019

ERRATUM ______________________

Appeal No. 2017-2312

DR. FALK PHARMA GMBH, Appellant

v.

GENERICO, LLC, FLAT LINE CAPITAL LLC, MYLAN PHARMACEUTICALS INC., Appellees -------------------------------------------------- Appeal Nos. 2017-2636, 2018-1320

SALIX PHARMACEUTICALS, INC., DR. FALK PHARMA GMBH, Plaintiffs-Appellants

v.

MYLAN PHARMACEUTICALS INC., MYLAN INC., Defendants-Appellees

Decided June 12, 2019 Nonprecedential Opinion 2 DR. FALK PHARMA GMBH v. GENERICO, LLC

______________________

The following change has been made: Page 16, line 16, “district court” has been changed to “Board.”

Free access — add to your briefcase to read the full text and ask questions with AI

Dr. Falk Pharma Gmbh v. Generico, LLC, (Fed. Cir. 2019).

Dr. Falk Pharma Gmbh v. Generico, LLC (Dr. Falk Pharma Gmbh v. Generico, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.